Product Code: ETC13227198 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 | |
According to 6Wresearch internal database and industry insights, the Global Denosumab Market was valued at USD 3.2 Billion in 2024 and is expected to reach USD 4.7 Billion by 2031, growing at a compound annual growth rate of 9.90% during the forecast period (2025-2031).
Global Denosumab Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Denosumab Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Denosumab Market Revenues & Volume, 2021 & 2031F |
3.3 Global Denosumab Market - Industry Life Cycle |
3.4 Global Denosumab Market - Porter's Five Forces |
3.5 Global Denosumab Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Denosumab Market Revenues & Volume Share, By Drug Classification, 2021 & 2031F |
3.7 Global Denosumab Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Global Denosumab Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Denosumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Denosumab Market Trends |
6 Global Denosumab Market, 2021 - 2031 |
6.1 Global Denosumab Market, Revenues & Volume, By Drug Classification, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Denosumab Market, Revenues & Volume, By Prolia, 2021 - 2031 |
6.1.3 Global Denosumab Market, Revenues & Volume, By Xgeva, 2021 - 2031 |
6.2 Global Denosumab Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Denosumab Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.2.3 Global Denosumab Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.2.4 Global Denosumab Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.2.5 Global Denosumab Market, Revenues & Volume, By Ambulatory Surgical Centres, 2021 - 2031 |
6.3 Global Denosumab Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Denosumab Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.3.3 Global Denosumab Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.3.4 Global Denosumab Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 North America Denosumab Market, Overview & Analysis |
7.1 North America Denosumab Market Revenues & Volume, 2021 - 2031 |
7.2 North America Denosumab Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Denosumab Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Denosumab Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Denosumab Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Denosumab Market, Revenues & Volume, By Drug Classification, 2021 - 2031 |
7.4 North America Denosumab Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5 North America Denosumab Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Denosumab Market, Overview & Analysis |
8.1 Latin America (LATAM) Denosumab Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Denosumab Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Denosumab Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Denosumab Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Denosumab Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Denosumab Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Denosumab Market, Revenues & Volume, By Drug Classification, 2021 - 2031 |
8.4 Latin America (LATAM) Denosumab Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.5 Latin America (LATAM) Denosumab Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Denosumab Market, Overview & Analysis |
9.1 Asia Denosumab Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Denosumab Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Denosumab Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Denosumab Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Denosumab Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Denosumab Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Denosumab Market, Revenues & Volume, By Drug Classification, 2021 - 2031 |
9.4 Asia Denosumab Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.5 Asia Denosumab Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Denosumab Market, Overview & Analysis |
10.1 Africa Denosumab Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Denosumab Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Denosumab Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Denosumab Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Denosumab Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Denosumab Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Denosumab Market, Revenues & Volume, By Drug Classification, 2021 - 2031 |
10.4 Africa Denosumab Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.5 Africa Denosumab Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Denosumab Market, Overview & Analysis |
11.1 Europe Denosumab Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Denosumab Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Denosumab Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Denosumab Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Denosumab Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Denosumab Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Denosumab Market, Revenues & Volume, By Drug Classification, 2021 - 2031 |
11.4 Europe Denosumab Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.5 Europe Denosumab Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Denosumab Market, Overview & Analysis |
12.1 Middle East Denosumab Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Denosumab Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Denosumab Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Denosumab Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Denosumab Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Denosumab Market, Revenues & Volume, By Drug Classification, 2021 - 2031 |
12.4 Middle East Denosumab Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.5 Middle East Denosumab Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Denosumab Market Key Performance Indicators |
14 Global Denosumab Market - Export/Import By Countries Assessment |
15 Global Denosumab Market - Opportunity Assessment |
15.1 Global Denosumab Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Denosumab Market Opportunity Assessment, By Drug Classification, 2021 & 2031F |
15.3 Global Denosumab Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.4 Global Denosumab Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Denosumab Market - Competitive Landscape |
16.1 Global Denosumab Market Revenue Share, By Companies, 2024 |
16.2 Global Denosumab Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |